J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 72 (1991), 2121-2127; DOI 10.1099/0022-1317-72-9-2121
© 1991 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cavanagh, H. M. A.
Right arrow Articles by Spibey, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavanagh, H. M. A.
Right arrow Articles by Spibey, N.
Agricola
Right arrow Articles by Cavanagh, H. M. A.
Right arrow Articles by Spibey, N.

A mutant of canine adenovirus type 2 with a duplication of the E1a region exhibits altered expression of early region 4

Heather M. A. Cavanagh{dagger}, Carina F. Gallagher and Norman Spibey

Department of Veterinary Pathology, University of Glasgow Veterinary School, Bearsden Road, Glasgow, U.K.

The genomic DNA of a vaccine strain of canine adenovirus type 2 (Vaxitas; ICI Tasman) has been shown to contain two copies of the E1a region, the second being at the far right end of the genome. DNA sequence analysis of the right terminal 2.8 kbp of this vaccine strain showed that numerous point mutations have occurred in the second copy, which would preclude the synthesis of any functional products. However, expression vectors in which the E1a promoter from the right terminus were linked to the chloramphenicol acetyltransferase gene showed that the promoter was fully functional. Furthermore, the activity of the reiterated E1a promoter was considerably greater than that of the normal E4 promoter. This dramatic change in the regulation of E4 expression may be an important factor in determining the altered host cell specificity displayed by this vaccine strain virus.

{dagger} Present address: Department of Neurovirology, University of Glasgow, Institute of Neurology, Southern General Hospital, Glasgow, U.K.

Received 31 October 1990; accepted 21 May 1991.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1991 by the Society for General Microbiology.